184 related articles for article (PubMed ID: 18318759)
1. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
Naess IA; Christiansen SC; Romundstad PR; Cannegieter SC; Blom HJ; Rosendaal FR; Hammerstrøm J
Br J Haematol; 2008 May; 141(4):529-35. PubMed ID: 18318759
[TBL] [Abstract][Full Text] [Related]
2. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
Den Heijer M; Lewington S; Clarke R
J Thromb Haemost; 2005 Feb; 3(2):292-9. PubMed ID: 15670035
[TBL] [Abstract][Full Text] [Related]
4. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
[TBL] [Abstract][Full Text] [Related]
5. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE).
Tsai AW; Cushman M; Tsai MY; Heckbert SR; Rosamond WD; Aleksic N; Yanez ND; Psaty BM; Folsom AR
Am J Hematol; 2003 Mar; 72(3):192-200. PubMed ID: 12605391
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
[TBL] [Abstract][Full Text] [Related]
8. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population.
Zhang W; Sun K; Chen J; Liao Y; Qin Q; Ma A; Wang D; Zhu Z; Wang Y; Hui R
Clin Sci (Lond); 2009 Oct; 118(3):187-94. PubMed ID: 19515015
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study).
Naess IA; Christiansen SC; Cannegieter SC; Rosendaal FR; Hammerstroem J
J Thromb Haemost; 2006 Jan; 4(1):44-9. PubMed ID: 16409447
[TBL] [Abstract][Full Text] [Related]
10. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss.
Nadir Y; Hoffman R; Brenner B
Ann Hematol; 2007 Jan; 86(1):35-40. PubMed ID: 17043779
[TBL] [Abstract][Full Text] [Related]
11. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
Fridman O; Porcile R; Vanasco V; Junco MN; Gariglio L; Potenzoni MA; Bañes I; Morales A
Clin Exp Hypertens; 2008 Oct; 30(7):574-84. PubMed ID: 18855261
[TBL] [Abstract][Full Text] [Related]
12. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986
[TBL] [Abstract][Full Text] [Related]
13. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
Keijzer MB; Borm GF; Blom HJ; Bos GM; Rosendaal FR; den Heijer M
Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768
[TBL] [Abstract][Full Text] [Related]
14. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study.
Feng LG; Song ZW; Xin F; Hu J
Psychiatry Res; 2009 Aug; 168(3):205-8. PubMed ID: 19564051
[TBL] [Abstract][Full Text] [Related]
15. Protective effect against alcohol dependence of the thermolabile variant of MTHFR.
Saffroy R; Benyamina A; Pham P; Marill C; Karila L; Reffas M; Debuire B; Reynaud M; Lemoine A
Drug Alcohol Depend; 2008 Jul; 96(1-2):30-6. PubMed ID: 18328637
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.
Todorović Z; Dzoljić E; Novaković I; Mirković D; Stojanović R; Nesić Z; Krajinović M; Prostran M; Kostić V
J Neurol Sci; 2006 Oct; 248(1-2):56-61. PubMed ID: 16774768
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk.
Gellekink H; Muntjewerff JW; Vermeulen SH; Hermus AR; Blom HJ; den Heijer M
Thromb Haemost; 2007 Dec; 98(6):1226-31. PubMed ID: 18064318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
